Delta Financial Group, Inc. Johnson & Johnson Transaction History

Delta Financial Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	SELL	$155.22 - $162.74 $137,369 - $144,024	-885 Reduced 3.5%	24,366 $3.86 Million
Q4 2023 Jan 18, 2024	SELL	$145.6 - $158.88 $113,422 - $123,767	-779 Reduced 2.99%	25,251 $3.96 Million
Q3 2023 Oct 31, 2023	BUY	$155.75 - $174.48 $4.05 Million - $4.54 Million	26,030 New	26,030 $4.05 Million
Q1 2023 Apr 25, 2023	BUY	$151.05 - $180.26 $70,540 - $84,181	467 Added 1.65%	28,774 $4.46 Million
Q4 2022 Feb 13, 2023	BUY	$160.2 - $179.79 $4.53 Million - $5.09 Million	28,307 New	28,307 $5.02 Million

4,275

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $379B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Delta Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Delta Financial Group, Inc. with notifications on news.